Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $290,960 - $334,760
-2,000 Reduced 58.82%
1,400 $226,000
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $274,322 - $299,782
1,900 Added 126.67%
3,400 $496,000
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $232,830 - $244,110
1,500 New
1,500 $237,000
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $1.87 Million - $2.24 Million
-12,400 Reduced 63.27%
7,200 $1.12 Million
Q4 2022

Feb 15, 2023

SELL
$160.2 - $179.79 $913,139 - $1.02 Million
-5,700 Reduced 22.53%
19,600 $3.46 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $2.86 Million - $3.16 Million
-17,000 Reduced 40.19%
25,300 $4.49 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $5.98 Million - $6.79 Million
37,800 Added 840.0%
42,300 $7.5 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $1.2 Million - $1.33 Million
-7,700 Reduced 63.11%
4,500 $770,000
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $1.44 Million - $1.6 Million
8,900 Added 269.7%
12,200 $1.97 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $526,284 - $564,531
3,300 New
3,300 $544,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.